Chronic HCV

March 1, 2016May 20, 2016

Chronic Hepatitis C Treatment Combo for Genotype 1b Patients Given a Positive Review by CHMP

News

Enanta Pharmaceuticals, Inc., announced that a European Medicines Agency (EMA) panel has given a positive review to the use of Viekirax (ombitasvir/paritaprevir/ritonavir tablets) plus Exviera (dasabuvir) without ribavirin (RBV) for the treatment of chronic ... Read more

February 2, 2016May 20, 2016

AbbVie’s Six Hepatitis C Clinical Trials Now Enrolling Patients

News

AbbVie has announced it will initiate six global Phase 3 clinical studies to evaluate the safety and efficacy of two drug candidates: ABT-530, an NS5A inhibitor, and ABT-493, an NS3/4A protease inhibitor, ... Read more

May 1, 2015May 1, 2015

ALLY-1 Clinical Trial Results Suggest Viable Chronic Hepatitis C Virus Treatment

Hepatitis C, News

In a recent press release from Bristol-Myers Squibb, officials announced the success of their ongoing phase III clinical trial, ALLY-1, in meeting its predicted end-points. The trial had been conducted among ... Read more